Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.19
Delayed Data
As of Dec 11
 +0.01 / +0.11%
Today’s Change
7.12
Today|||52-Week Range
11.63
+7.23%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Ross Steven A
Chief Information Officer
Sale6/05/201745,833$7.79$357.0K+18.12%
Van Oort Douglas M
Chairman & Chief Executive Officer
Sale2/02/201742,015$8.14$342.0K+14.16%
Van Oort Douglas M
Chairman & Chief Executive Officer
Buy2/02/2017200,000$1.71$342.0K+14.16%
Brodie Steven G
President-Pharmaceutical Services
Sale3/20/201733,450$7.90$264.3K+16.33%
Balliet Jennifer
Sale8/24/201722,500$9.38$211.1K-3.16%
Hannah Alison L
Director
Buy7/27/201720,000$9.19$183.8K-0.86%
Jones Steven C
Executive Vice President-Finance
Gift12/27/201620,000$8.92$178.4K+3.84%
Ross Steven A
Chief Information Officer
Buy6/02/201733,333$4.78$159.3K+17.97%
Ross Steven A
Chief Information Officer
Buy6/02/201737,500$3.93$147.4K+17.97%
Brodie Steven G
President-Pharmaceutical Services
Sale3/13/201716,550$8.00$132.4K+16.18%
Page of 3